European Journal of Chemistry

Design, synthesis, and biological profile of novel N-(5-aryl-1,3,4-thiadiazol-2-yl) hydrazinecarboxamides

Article Sidebar

PDF
Published: Sep 30, 2014
DOI: https://doi.org/10.5155/eurjchem.5.3.488-496.1073
Keywords:
ELISA, Thiadiazoles, Arylthiadiazole, Anticonvulsants, Immunomodulatory, Hydrazinecarboxamides
Section
Research Article
Issue
Vol. 5 No. 3 (2014): September 2014
Dates
Received 2014-04-10
Accepted 2014-04-29
Published 2014-09-30


Main Article Content

Mohammed Farrag El-Behairy
Medicinal and Pharmaceutical Chemistry Department, Pharmaceutical and Drug Industries Research Division, National Research Centre, Dokki, 12311, Cairo, Egypt
Mohamed Nabil Aboul-Enein
Medicinal and Pharmaceutical Chemistry Department, Pharmaceutical and Drug Industries Research Division, National Research Centre, Dokki, 12311, Cairo, Egypt
Aida Abdel-Sattar El-Azzouny
Medicinal and Pharmaceutical Chemistry Department, Pharmaceutical and Drug Industries Research Division, National Research Centre, Dokki, 12311, Cairo, Egypt
Ola Ahmed Saleh
Medicinal and Pharmaceutical Chemistry Department, Pharmaceutical and Drug Industries Research Division, National Research Centre, Dokki, 12311, Cairo, Egypt
Yousreya Aly Maklad
Medicinal and Pharmaceutical Chemistry Department, Pharmaceutical and Drug Industries Research Division, National Research Centre, Dokki, 12311, Cairo, Egypt
Mona Elsayed Aboutabl
Medicinal and Pharmaceutical Chemistry Department, Pharmaceutical and Drug Industries Research Division, National Research Centre, Dokki, 12311, Cairo, Egypt
Amany Sayed Maghraby
Therapeutic Chemistry Department, Pharmaceutical and Drug Industries Research Division, Immunology and Infectious Diseases Laboratory, Centre of Excellence for Advanced Sciences, National Research Centre, Dokki, 12311, Cairo, Egypt

Abstract

New series of arylthiadiazole hydrazinecarboxamides (5a-e) have been synthesized by hydrazinolysis of carbamates (4a-e) and spectrally characterized. The new candidates have been screened for their anticonvulsant and immunomodulatory activities. Compound 5e was the most potent anticonvulsant candidate as it showed 100% protection against both maximal electroshock seizure (MES) and subcutaneous pentylenetetrazole (scPTZ) screens without neurotoxicity at 100 mg/kg (0.318 mmol/kg). With respect to immunomodulation, compounds 5a and 5d revealed immunostimulatory activity while compounds 5b, 5c, and 5e had immunosuppressive responses based on ELISA detection of IgM and IgG levels, counting the total mesenteric lymph nodes lymphocytes, and histo-pathological examinations.


icon graph This Abstract was viewed 3663 times | icon graph Article PDF downloaded 925 times

How to Cite
(1)
El-Behairy, M. F.; Aboul-Enein, M. N.; El-Azzouny, A. A.-S.; Saleh, O. A.; Maklad, Y. A.; Aboutabl, M. E.; Maghraby, A. S. Design, Synthesis, and Biological Profile of Novel N-(5-Aryl-1,3,4-Thiadiazol-2-Yl) Hydrazinecarboxamides. Eur. J. Chem. 2014, 5, 488-496.

Article Details

Share
Links for Article


Crossref - Scopus - Google - European PMC
Crossref
Scopus
Google Scholar
Europe PMC
References

[1]. Masihi, K. N. Immunotherapy of Infections, 1st edition, New York: Marcel Dekker, 1994.

[2]. Masihi, K. N. Int. J. Immunopharmacol. 1997, 19, 463-617.
http://dx.doi.org/10.1016/S0192-0561(97)00056-8

[3]. Foroumadi, A.; Jazayeri, S.; Moshafi, M. H.; Firoozpour, L.; Emami, S.; Rajabalian, S.; Haddad, M.; Pahlavanzadeh, F.; Esnaashari, M.; Shafiee, A. Eur. J. Med. Chem. 2009, 44, 1205-1209.
http://dx.doi.org/10.1016/j.ejmech.2008.09.012

[4]. Goksen, U. S.; Kelekci, N. G.; Goktas, O.; Koysal, Y.; Kilic, E.; Isik, S.; Aktay, G.; Ozalp, M. Bioorg. Med. Chem. 2007, 15, 5738-5751.
http://dx.doi.org/10.1016/j.bmc.2007.06.006

[5]. Mavrova, A. T.; Wesselinova, D.; Tsenov, Y. A.; Denkova, P. Eur. J. Med. Chem. 2009, 44, 63-69.
http://dx.doi.org/10.1016/j.ejmech.2008.03.006

[6]. Pattanayak, P.; Sharma, R.; Sahoo, P. K. Med. Chem. Res. 2009, 18, 351-361.
http://dx.doi.org/10.1007/s00044-008-9132-1

[7]. Kus, C.; Kilcigil, G. A.; Ozbey, S.; Kaynak, F. B.; Kaya, M.; Coban, T.; Eke, B. C. Bioorg. Med. Chem. 2008, 16, 4294-4303.
http://dx.doi.org/10.1016/j.bmc.2008.02.077

[8]. Behrouzi-Fardmoghadam, M.; Poorrajab, F.; Ardestani, S. K.; Emami, S.; Shafieea, A.; Foroumadi, A. Bioorg. Med. Chem. 2008, 16, 4509-4515.
http://dx.doi.org/10.1016/j.bmc.2008.02.052

[9]. Bhuva, H.; Sahu, D.; Shaha, B.; Modia, D.; Patel, M. Pharmacology Online 2011, 1, 528-543.

[10]. Takezawa, R.; Cheng, H.; Beck, A.; Ishikawa, J.; Launay, P.; Kubota, H.; Kinet, J. P.; Fleig, A.; Yamada, T.; Penner, R. Mol. Pharmacol. 2006, 69, 1413-1420.
http://dx.doi.org/10.1124/mol.105.021154

[11]. Yoshino, T.; Ishikawa, J.; Ohga, K.; Morokata, T.; Takezawa, R.; Morio, H.; Okada, Y.; Honda, K.; Yamada, T. Eur. J. Pharm. 2007, 560, 225-233.
http://dx.doi.org/10.1016/j.ejphar.2007.01.012

[12]. Vo, N. H.; Chen, S.; Che, S. US patent US 2007/0254925 A1, 2007.

[13]. Jingwu, D.; Bin, J. WO 2007/073503 A2, 2007.

[14]. Beraldo, H.; Gambinob, D. Mini Rev. Med. Chem. 2004, 4, 31-39.
http://dx.doi.org/10.2174/1389557043487484

[15]. Rajak, H. R.; Avantika, A.; Poonam, P.; Singh, T. B.; Ravichandran, V.; Chander, S. P.; Dhar, K. M. Bioorg. Med. Chem. Lett. 2011, 21, 5735-5738.
http://dx.doi.org/10.1016/j.bmcl.2011.08.022

[16]. Tu, G. G.; Huang, H. H.; Li, G.; Xiong, F.; Mai, X.; Zhu, H. W.; Kuang, B. H.; Xu, W. H. Bioorg. Med. Chem. 2008, 16, 6663-6668.
http://dx.doi.org/10.1016/j.bmc.2008.05.081

[17]. Rango, R. V.; Srinivasan, V. R. Indian J. Chem. 1970, 8, 509-513.

[18]. Pryde, D. C.; Maw, G. N.; Planken, S.; Platts, M. Y.; Sanderson, V.; Corless, M.; Stobie, A.; Barber, C. G.; Russell, R.; Foster, L.; Barker, L.; Wayman, C.; Van der Graaf, P.; Stacey, P.; Morren, D.; Kohl, C.; Beaumount, K.; Coggon, S.; Tute, M. J. Med. Chem. 2006, 49, 4409-4424.
http://dx.doi.org/10.1021/jm060133g

[19]. Doyle, K. M.; Kurzer, F. Tetrahedron 1976, 32, 2347-2352.
http://dx.doi.org/10.1016/0040-4020(76)88013-1

[20]. Fariello, R. G.; McArthur, R. A.; Bonsignori, A.; Cervini, M. A.; Maj, R.; Marrari, P.; Pevarello, P.; Wolf, H. H.; Woodhead, J. W.; White, H. S.; Varasi, M.; Salvati, P.; Post, C. J. Pharm. Exp. Therap. 1998, 285, 397-403.

[21]. Alam, O.; Mullick, P.; Verma, S. P.; Gilani, S. J.; Khan, S. A.; Siddiqui, N.; Ahsan, W. Eur. J. Med. Chem. 2010, 45, 2467-2472.
http://dx.doi.org/10.1016/j.ejmech.2010.02.031

[22]. Krall, R. L.; Penry, J. K.; White, B. G.; Kupferberg, H. J.; Swinyard, E. A. Epilepsia 1978, 19, 409-428.
http://dx.doi.org/10.1111/j.1528-1157.1978.tb04507.x

[23]. Luszczki, J. J.; Czuczwar, M.; Gawlik, P.; Sawiniec-Pozniak, G.; Czuczwar, K.; Czuczwar, S. J. J. Neural. Transm. 2006, 113, 1157-1168.
http://dx.doi.org/10.1007/s00702-005-0417-y

[24]. Dunham, N. W.; Miya, T. S. Amer. Pharm. Assoc. 1957, 46, 208-209.
http://dx.doi.org/10.1002/jps.3030460322

[25]. Maghraby, A.; Bahgat, M. Arzneimittel-Forschung, 2004, 54, 545-550.

[26]. Maghraby, A., M. Sc. Thesis submitted to the faculty of science, Cairo University, Egypt, 1989, p. 43-46.

[27]. Augustine, J. K.; Vairaperumal, V.; Narasimhan, S.; Alagarsamy, P.; Radhakrishnan, A. Tetrahedron 2009, 65, 9989-9996.
http://dx.doi.org/10.1016/j.tet.2009.09.114

[28]. Yadav, J. S.; Reddy, G. S.; Reddy, M. M.; Meshram, H. M. Tetrahedron Lett. 1998, 39, 3259-3262.
http://dx.doi.org/10.1016/S0040-4039(98)00464-X

[29]. Balack, D. A.; Arndtsen, B. A. Org. Lett. 2006, 8, 1991-1993.
http://dx.doi.org/10.1021/ol060277p

[30]. Elghamry, I. Synthetic Commun. 2009, 39, 3010-3015.
http://dx.doi.org/10.1080/00397910802564741

[31]. Lebel, H.; Leogane, O. Org. Lett. 2006, 8, 5717-5720.
http://dx.doi.org/10.1021/ol0622920

[32]. Lebel, H.; Leogane, O. Org. Lett. 2005, 7, 4107-4110.
http://dx.doi.org/10.1021/ol051428b

[33]. Han, C.; Porco, J. A. Jr. Org. Lett. 2007, 9, 1517-1520.
http://dx.doi.org/10.1021/ol0702728

[34]. Curini, M.; Epifano, F.; Maltese, F.; Rosati, O. Tetrahedron Lett. 2002, 43, 4895-4897.
http://dx.doi.org/10.1016/S0040-4039(02)00965-6

[35]. Caddick, S.; Judd, D. B.; Lewis, K.; Reich, M. T.; Williams, M. R. V. Tetrahedron 2003, 59, 5417-5423.
http://dx.doi.org/10.1016/S0040-4020(03)00858-5

[36]. Sun, C.; Weinreb, S. Synthesis 2006, 3585-3588.

[37]. White, H. S. Epilepsia 2003, 44, 2-8.
http://dx.doi.org/10.1046/j.1528-1157.44.s7.10.x

[38]. Porter, R. J.; Cereghino, J. J.; Gladding, G. D.; Hessie, B. J.; Kupferberg, H. J.; Scoville, B.; White, B. G. Cleveland Clin. Q. 1984, 51, 293-305.
http://dx.doi.org/10.3949/ccjm.51.2.293

[39]. Amir, M.; Kumar, H.; Javed, S. A. Eur. J. Med. Chem. 2008, 43, 2056-2066.
http://dx.doi.org/10.1016/j.ejmech.2007.09.025

Supporting Agencies

National Research Centre (Project No, 10010302), Dokki, Cairo, Egypt
Most read articles by the same author(s)

Most read articles by the same author(s)

TrendMD

Dimensions - Altmetric - scite_ - PlumX

Downloads and views

Downloads

Download data is not yet available.

Metrics

Metrics Loading ...
License Terms

License Terms

by-nc

Copyright © 2024 by Authors. This work is published and licensed by Atlanta Publishing House LLC, Atlanta, GA, USA. The full terms of this license are available at https://www.eurjchem.com/index.php/eurjchem/terms and incorporate the Creative Commons Attribution-Non Commercial (CC BY NC) (International, v4.0) License (http://creativecommons.org/licenses/by-nc/4.0). By accessing the work, you hereby accept the Terms. This is an open access article distributed under the terms and conditions of the CC BY NC License, which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited without any further permission from Atlanta Publishing House LLC (European Journal of Chemistry). No use, distribution, or reproduction is permitted which does not comply with these terms. Permissions for commercial use of this work beyond the scope of the License (https://www.eurjchem.com/index.php/eurjchem/terms) are administered by Atlanta Publishing House LLC (European Journal of Chemistry).